MG
About
MiMedx Group developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. They processes the human placental tissue utilizing its proprietary purion process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 25 investors are based in Marietta, Georgia, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech martech
- Location
- Marietta, US
Contact Information
Find more investors like MiMedx
Search Investors